Gilead Sciences (GILD) is a company which I have been following for some time.  In January 2017 I wrote an article on Seeking Alpha describing why I felt that Gilead Sciences could be a core holding in a portfolio.  In today’s post, I’ll be sharing my notes from Gilead Sciences earnings call for the 4th quarter […]